Evidence map›Paper›PMID 33209971›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2020

Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment.

Eric E Smith, Philip Barber, Thalia S Field, Aravind Ganesh, Vladimir Hachinski, David B Hogan, Krista L Lanctôt, M Patrice Lindsay, Mukul Sharma, Richard H Swartz and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 5 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 5 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Efficacy and safety ofFrontiers in pharmacology · 2026
    Pooled it
  3. Guideline
  4. Guideline
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. [PAPPS update on older people 2022].Atencion primaria · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Rapid recommendations: Updates from 2020 guidelines: part 2.Canadian family physician Medecin de famille canadien · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Eric E SmithDepartment of Clinical Neurosciences and Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada.
Philip BarberDepartment of Clinical Neurosciences and Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada.
Thalia S FieldVancouver Stroke Program Djavad Mowafaghian Centre for Brain Health, Division of Neurology University of British Columbia Vancouver British Columbia Canada.
Aravind GaneshDepartment of Clinical Neurosciences University of Calgary Calgary Alberta Canada.
Vladimir HachinskiDepartment of Clinical Neurological Sciences Western University London Ontario Canada.
David B HoganDepartment of Medicine and Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada.
Krista L LanctôtDepartment of Psychiatry and Hurvitz Brain Sciences Research Program Sunnybrook Research Institute and Departments of Psychiatry and Pharmacology University of Toronto Toronto Ontario Canada.
M Patrice LindsayHeart and Stroke Foundation of Canada Toronto Ontario Canada.
Mukul SharmaDepartment of Medicine (Neurology) Population Health Research Institute McMaster University Canada.
Richard H SwartzDepartment of Medicine (Neurology) Hurvitz Brain Sciences Program Sunnybrook HSC University of Toronto Toronto Canada.
Zahinoor IsmailDepartments of Psychiatry Clinical Neurosciences and Community Health Sciences Hotchkiss Brain Institute and O'Brien Institute for Public Health University of Calgary Calgary Canada.
Serge GauthierMcGill Center for Studies in Aging McGill University Montreal Canada.
Sandra E BlackDepartment of Medicine (Neurology) Hurvitz Brain Sciences Research Program LC Campbell Cognitive Neurology Unit Canadian Partnership for Stroke Recovery University of Toronto Toronto Canada.
University of Calgary · CASunnybrook Health Science Centre · CAHeart and Stroke Foundation · CAMcGill University · CAPopulation Health Research Institute · CAUniversity of British Columbia · CAUniversity of Toronto · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVascular disease is a common cause of dementia, and often coexists with other brain pathologies such as Alzheimer's disease to cause mixed dementia. Many of the risk factors for vascular disease are treatable. Our objective was to review evidence for diagnosis and treatment of vascular cognitive impairment (VCI) to issue recommendations to clinicians.

methodsA subcommittee of the Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD) reviewed areas of emerging evidence. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used to assign the quality of the evidence and strength of the recommendations.

resultsUsing standardized diagnostic criteria, managing hypertension to conventional blood pressure targets, and reducing risk for stroke are strongly recommended. Intensive blood pressure lowering in middle-aged adults with vascular risk factors, using acetylsalicylic acid in persons with VCI and covert brain infarctions but not if only white matter lesions are present, and using cholinesterase inhibitors are weakly recommended.

conclusionsThe CCCDTD has provided evidence-based recommendations for diagnosis and management of VCI for use nationally in Canada, that may also be of use worldwide.

Indexed as

dementiaguidelinesvascular cognitive impairmentvascular dementia

Identifiers

PMID33209971
PMCPMC7657196
OpenAlexW3103200060

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.